Masimo (NASDAQ:MASI) Hits New 12-Month High – Time to Buy?

Masimo Corporation (NASDAQ:MASI) shares reached a new 52-week high during trading on Wednesday . The company traded as high as $180.02 and last traded at $178.6250, with a volume of 2581 shares trading hands. The stock had previously closed at $178.55.

Analyst Ratings Changes

A number of analysts recently commented on MASI shares. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Stifel Nicolaus set a $180.00 price objective on shares of Masimo in a research report on Tuesday, February 17th. Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Finally, Raymond James Financial cut shares of Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Nine analysts have rated the stock with a Hold rating, According to MarketBeat, Masimo currently has a consensus rating of “Hold” and an average target price of $180.40.

Masimo Stock Performance

The stock has a fifty day simple moving average of $177.60 and a 200-day simple moving average of $155.29. The stock has a market cap of $9.35 billion, a P/E ratio of -16.93, a PEG ratio of 1.81 and a beta of 1.13. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68.

Hedge Funds Weigh In On Masimo

A number of large investors have recently modified their holdings of MASI. Naya Capital Management UK Ltd. acquired a new stake in Masimo in the 4th quarter valued at about $202,984,000. AQR Capital Management LLC lifted its stake in Masimo by 3,416.5% in the 4th quarter. AQR Capital Management LLC now owns 1,091,326 shares of the medical equipment provider’s stock valued at $141,938,000 after purchasing an additional 1,060,292 shares during the last quarter. Viking Global Investors LP acquired a new stake in Masimo in the 2nd quarter valued at about $129,096,000. Squarepoint Ops LLC lifted its stake in Masimo by 738.8% in the 3rd quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider’s stock valued at $91,619,000 after purchasing an additional 546,905 shares during the last quarter. Finally, SG Americas Securities LLC lifted its stake in Masimo by 3,082.3% in the 1st quarter. SG Americas Securities LLC now owns 522,824 shares of the medical equipment provider’s stock valued at $92,995,000 after purchasing an additional 506,395 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.